|
2024
|
Invention
|
Multi-parameter metabolic vulnerability index evaluations.
Disclosed are methods and systems to ... |
|
|
Invention
|
Cardiovascular risk evaluations using a risk parameter that includes an hdl and inflammatory biom... |
|
|
Invention
|
Multiple-marker risk parameters predictive of conversion to diabetes.
Methods, systems and circu... |
|
|
Invention
|
Methods, systems and computer programs for assessing chd risk using adjusted hdl particle number ... |
|
2023
|
Invention
|
Nmr quantification of tmao.
A defined peak region residing between about 3.2 and 3.4 ppm of a pr... |
|
|
Invention
|
Metabolic vulnerability analyzed by nmr.
Disclosed are methods and systems for evaluating variou... |
|
|
Invention
|
Metabolic vulnerability analyzed by nmr. Disclosed are methods and systems for evaluating various... |
|
|
Invention
|
Multi-parameter diabetes risk evaluations.
Methods, systems and circuits evaluate a subject's ri... |
|
2022
|
Invention
|
Methods and systems to detect and quantify the amount of lp-x and other abnormal lipoproteins in ... |
|
2021
|
Invention
|
Nmr system and methods for multi-parameter metabolic vulnerability index evaluations. Disclosed a... |
|
|
Invention
|
Nmr analyzers for clinical evaluation of biosamples.
The clinical analyzers automatically electr... |
|
|
Invention
|
Multiple-marker risk parameters predictive of conversion to diabetes. Methods, systems and circui... |
|
2020
|
Invention
|
Nmr measurements of nmr biomarker glyca. Biomarkers and/or risk assessments identify patients hav... |
|
|
Invention
|
Nmr quantification of tmao. A defined peak region residing between about 3.2 and 3.4 ppm of a pro... |
|
2019
|
Invention
|
Methods to predict liver disease mortality using lipoprotein lp-z.
Described herein are methods ... |
|
|
Invention
|
Methods to predict liver disease mortality using lipoprotein lp-z. Described herein are methods f... |
|
|
Invention
|
Chd risk stratification evaluations for subjects with high levels of large hdl-p. Embodiments of ... |
|
|
Invention
|
Multi-parameter diabetes risk evaluations. Methods, systems and circuits evaluate a subject's ris... |
|
|
Invention
|
Nmr analyzers for clinical evaluation of biosamples. The clinical analyzers automatically electro... |
|
2018
|
Invention
|
Multi-parameter metabolic vulnerability index evaluations. Disclosed are methods and systems to d... |
|
2017
|
Invention
|
Quantitative nmr clinical analyzers with automatic nmr temperature sensitivity compensation that ... |
|
|
Invention
|
Methods and systems for predicting colorectal cancer incidence and mortality. Disclosed are metho... |
|
2016
|
Invention
|
Methods, systems and computer programs for assessing chd risk using adjusted hdl article number m... |
|
2013
|
Invention
|
Nmr quantification of branched chain amino acids. The present invention relates generally to the ... |
|
|
Invention
|
Nmr measurements of glyca. Biomarkers and/or risk assessments identify patients having an increas... |
